BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Total assets

annual total assets:

$490.42M-$26.54M(-5.13%)
December 31, 2024

Summary

  • As of today (July 13, 2025), BCRX annual total assets is $490.42 million, with the most recent change of -$26.54 million (-5.13%) on December 31, 2024.
  • During the last 3 years, BCRX annual total assets has fallen by -$97.73 million (-16.62%).
  • BCRX annual total assets is now -16.62% below its all-time high of $588.15 million, reached on December 31, 2021.

Performance

BCRX Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly total assets:

$480.05M-$10.37M(-2.12%)
March 31, 2025

Summary

  • As of today (July 13, 2025), BCRX quarterly total assets is $480.05 million, with the most recent change of -$10.37 million (-2.12%) on March 31, 2025.
  • Over the past year, BCRX quarterly total assets has increased by +$12.15 million (+2.60%).
  • BCRX quarterly total assets is now -18.38% below its all-time high of $588.15 million, reached on December 31, 2021.

Performance

BCRX quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

BCRX Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.1%+2.6%
3 y3 years-16.6%-9.0%
5 y5 years+179.8%+251.4%

BCRX Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-16.6%at low-14.1%+2.6%
5 y5-year-16.6%+179.8%-18.4%+172.4%
alltimeall time-16.6%+3731.4%-18.4%+4848.9%

BCRX Total assets History

DateAnnualQuarterly
Mar 2025
-
$480.05M(-2.1%)
Dec 2024
$490.42M(-5.1%)
$490.42M(-0.2%)
Sep 2024
-
$491.25M(+4.0%)
Jun 2024
-
$472.42M(+1.0%)
Mar 2024
-
$467.89M(-9.5%)
Dec 2023
$516.96M(-6.0%)
$516.96M(-1.1%)
Sep 2023
-
$522.92M(-1.3%)
Jun 2023
-
$529.88M(+4.0%)
Mar 2023
-
$509.74M(-7.3%)
Dec 2022
$550.00M(-6.5%)
$550.00M(-1.5%)
Sep 2022
-
$558.59M(+9.4%)
Jun 2022
-
$510.54M(-3.3%)
Mar 2022
-
$527.72M(-10.3%)
Dec 2021
$588.15M(+75.7%)
$588.15M(+121.3%)
Sep 2021
-
$265.76M(-4.2%)
Jun 2021
-
$277.28M(-2.5%)
Mar 2021
-
$284.43M(-15.0%)
Dec 2020
$334.71M(+91.0%)
$334.71M(+89.9%)
Sep 2020
-
$176.23M(-17.9%)
Jun 2020
-
$214.71M(+57.2%)
Mar 2020
-
$136.59M(-22.1%)
Dec 2019
$175.28M(+19.4%)
$175.28M(+93.7%)
Sep 2019
-
$90.50M(-22.2%)
Jun 2019
-
$116.34M(-18.3%)
Mar 2019
-
$142.34M(-3.1%)
Dec 2018
$146.84M(-17.6%)
$146.84M(-12.8%)
Sep 2018
-
$168.31M(+23.2%)
Jun 2018
-
$136.64M(-12.1%)
Mar 2018
-
$155.37M(-12.8%)
Dec 2017
$178.26M(+98.4%)
$178.26M(-6.9%)
Sep 2017
-
$191.49M(+68.7%)
Jun 2017
-
$113.51M(-12.4%)
Mar 2017
-
$129.51M(+44.1%)
Dec 2016
$89.85M(-26.6%)
$89.85M(-1.8%)
Sep 2016
-
$91.50M(+11.3%)
Jun 2016
-
$82.22M(-20.1%)
Mar 2016
-
$102.88M(-15.9%)
Dec 2015
$122.36M(-10.6%)
$122.36M(-11.9%)
Sep 2015
-
$138.96M(-7.5%)
Jun 2015
-
$150.18M(+15.6%)
Mar 2015
-
$129.87M(-5.1%)
Dec 2014
$136.87M(+180.1%)
$136.87M(-0.2%)
Sep 2014
-
$137.13M(-3.4%)
Jun 2014
-
$141.97M(+227.2%)
Mar 2014
-
$43.39M(-11.2%)
Dec 2013
$48.87M(-14.9%)
$48.87M(-8.2%)
Sep 2013
-
$53.20M(+33.3%)
Jun 2013
-
$39.92M(-14.9%)
Mar 2013
-
$46.90M(-18.3%)
Dec 2012
$57.44M(-30.1%)
$57.44M(-10.4%)
Sep 2012
-
$64.09M(-15.9%)
Jun 2012
-
$76.24M(-4.8%)
Mar 2012
-
$80.08M(-2.6%)
Dec 2011
$82.21M(-24.9%)
$82.21M(-11.1%)
Sep 2011
-
$92.51M(-14.7%)
Jun 2011
-
$108.41M(-11.7%)
Mar 2011
-
$122.77M(+12.2%)
Dec 2010
$109.45M(-23.0%)
$109.45M(-1.7%)
Sep 2010
-
$111.35M(-4.1%)
Jun 2010
-
$116.10M(-6.9%)
Mar 2010
-
$124.66M(-12.3%)
Dec 2009
$142.19M
$142.19M(+134.7%)
DateAnnualQuarterly
Sep 2009
-
$60.59M(-6.3%)
Jun 2009
-
$64.69M(-10.9%)
Mar 2009
-
$72.60M(-14.3%)
Dec 2008
$84.69M(-40.7%)
$84.69M(-14.8%)
Sep 2008
-
$99.35M(-7.7%)
Jun 2008
-
$107.65M(-16.6%)
Mar 2008
-
$129.14M(-9.5%)
Dec 2007
$142.72M(+108.4%)
$142.72M(+1.1%)
Sep 2007
-
$141.15M(+80.0%)
Jun 2007
-
$78.43M(+15.5%)
Mar 2007
-
$67.92M(-0.8%)
Dec 2006
$68.49M(-31.0%)
$68.49M(-14.6%)
Sep 2006
-
$80.20M(-12.7%)
Jun 2006
-
$91.88M(-10.1%)
Mar 2006
-
$102.22M(+3.0%)
Dec 2005
$99.25M(+205.7%)
$99.25M(+160.1%)
Sep 2005
-
$38.15M(-12.1%)
Jun 2005
-
$43.42M(-12.3%)
Mar 2005
-
$49.49M(+52.4%)
Dec 2004
$32.47M(+7.9%)
$32.47M(-14.3%)
Sep 2004
-
$37.88M(-9.3%)
Jun 2004
-
$41.77M(-9.1%)
Mar 2004
-
$45.95M(+52.7%)
Dec 2003
$30.10M(-27.1%)
$30.10M(-6.6%)
Sep 2003
-
$32.24M(-9.8%)
Jun 2003
-
$35.74M(-7.3%)
Mar 2003
-
$38.56M(-6.6%)
Dec 2002
$41.30M(-30.1%)
$41.30M(-6.3%)
Sep 2002
-
$44.09M(-7.9%)
Jun 2002
-
$47.88M(-10.0%)
Mar 2002
-
$53.17M(-10.0%)
Dec 2001
$59.10M(-16.6%)
$59.10M(-6.0%)
Sep 2001
-
$62.85M(-4.1%)
Jun 2001
-
$65.55M(-3.7%)
Mar 2001
-
$68.07M(-3.9%)
Dec 2000
$70.83M(-3.5%)
$70.83M(-2.1%)
Sep 2000
-
$72.38M(-2.7%)
Jun 2000
-
$74.38M(-1.9%)
Mar 2000
-
$75.83M(+3.3%)
Dec 1999
$73.40M(+152.2%)
$73.40M(+178.0%)
Sep 1999
-
$26.40M(-0.4%)
Jun 1999
-
$26.50M(-0.7%)
Mar 1999
-
$26.70M(-8.2%)
Dec 1998
$29.10M(+9.8%)
$29.10M(+18.8%)
Sep 1998
-
$24.50M(+15.0%)
Jun 1998
-
$21.30M(-13.1%)
Mar 1998
-
$24.50M(-7.5%)
Dec 1997
$26.50M(-28.6%)
$26.50M(-10.8%)
Sep 1997
-
$29.70M(-8.0%)
Jun 1997
-
$32.30M(-5.6%)
Mar 1997
-
$34.20M(-7.8%)
Dec 1996
$37.10M(+183.2%)
$37.10M(+4.8%)
Sep 1996
-
$35.40M(+79.7%)
Jun 1996
-
$19.70M(+3.1%)
Mar 1996
-
$19.10M(+45.8%)
Dec 1995
$13.10M(+2.3%)
$13.10M(-11.5%)
Sep 1995
-
$14.80M(-12.4%)
Jun 1995
-
$16.90M(+74.2%)
Mar 1995
-
$9.70M(-24.2%)
Dec 1994
$12.80M
$12.80M(-12.9%)
Sep 1994
-
$14.70M(-2.0%)
Jun 1994
-
$15.00M(-12.3%)
Mar 1994
-
$17.10M

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual total assets?
  • What is the all time high annual total assets for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual total assets year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly total assets?
  • What is the all time high quarterly total assets for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly total assets year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual total assets?

The current annual total assets of BCRX is $490.42M

What is the all time high annual total assets for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual total assets is $588.15M

What is BioCryst Pharmaceuticals, Inc. annual total assets year-on-year change?

Over the past year, BCRX annual total assets has changed by -$26.54M (-5.13%)

What is BioCryst Pharmaceuticals, Inc. quarterly total assets?

The current quarterly total assets of BCRX is $480.05M

What is the all time high quarterly total assets for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly total assets is $588.15M

What is BioCryst Pharmaceuticals, Inc. quarterly total assets year-on-year change?

Over the past year, BCRX quarterly total assets has changed by +$12.15M (+2.60%)
On this page